The use of dantrolene sodium in disorders of the central nervous system.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007596:Joints / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009132:Muscles / Q000187:drug effects; D010919:Placebos; D012026:Reflex, Stretch
D006827:Hydantoins; D009125:Muscle Relaxants, Central; D010919:Placebos